{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:21:17Z","timestamp":1787314877175,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00259-023-06290-5","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:01:26Z","timestamp":1686614486000},"page":"3375-3389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-0206","authenticated-orcid":false,"given":"Guido","family":"Rovera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"de Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-0633","authenticated-orcid":false,"given":"Vittoria","family":"Rufini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Zollino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Zagaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Vidal-Sicart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Vald\u00e9s Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-9767","authenticated-orcid":false,"given":"Angela","family":"Collarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"6290_CR1","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1007\/PL00014793","volume":"26","author":"AJ Wilhelm","year":"1999","unstructured":"Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection - an overview. Eur J Nucl Med. 1999;26:S36-42.","journal-title":"Eur J Nucl Med"},{"key":"6290_CR2","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s00259-013-2544-2","volume":"40","author":"F Giammarile","year":"2013","unstructured":"Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1932\u201347.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR3","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s00259-015-3135-1","volume":"42","author":"C Bluemel","year":"2015","unstructured":"Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42:1750\u201366.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00259-018-4235-5","volume":"46","author":"F Giammarile","year":"2019","unstructured":"Giammarile F, Schilling C, Gnanasegaran G, Bal C, Oyen WJG, Rubello D, et al. The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46:623\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR5","first-page":"951","volume":"42","author":"DR Vera","year":"2001","unstructured":"Vera DR, Wallace AM, Hoh CK, Mattrey RF. A synthetic macromolecule for sentinel node detection: 99mTc-DTPA-mannosyl-dextran. J Nucl Med. 2001;42:951\u20139.","journal-title":"J Nucl Med"},{"key":"6290_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1245\/ASO.2003.07.012","volume":"10","author":"AM Wallace","year":"2003","unstructured":"Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003;10:531\u20138.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR7","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"6290_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"6290_CR9","unstructured":"StataCorp. Stata Statistical Software: release 14. College Station, TX: StataCorp LP. College Station, TX: StataCorp LP: StataCorp LP; 2015."},{"key":"6290_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1245\/s10434-006-9099-4","volume":"14","author":"AM Wallace","year":"2007","unstructured":"Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007;14:913\u201321.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.nucmedbio.2007.05.003","volume":"34","author":"AM Wallace","year":"2007","unstructured":"Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007;34:849\u201353.","journal-title":"Nucl Med Biol"},{"key":"6290_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.nucmedbio.2009.04.007","volume":"36","author":"AM Wallace","year":"2009","unstructured":"Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a \u201c2-day\u201d protocol. Nucl Med Biol. 2009;36:687\u201392.","journal-title":"Nucl Med Biol"},{"key":"6290_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1245\/s10434-010-1524-z","volume":"18","author":"SPL Leong","year":"2011","unstructured":"Leong SPL, Kim J, Ross M, Faries M, Scoggins CR, Metz WLR, et al. A phase 2 study of 99mTc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Ann Surg Oncol. 2011;18:961\u20139.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1245\/s10434-012-2612-z","volume":"20","author":"VK Sondak","year":"2013","unstructured":"Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SPL, et al. Combined analysis of phase III trials evaluating [99mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol. 2013;20:680\u20138.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR15","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1245\/s10434-013-2887-8","volume":"20","author":"AM Wallace","year":"2013","unstructured":"Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, et al. Comparative evaluation of [99mTc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013;20:2590\u20139.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoto.2013.4239","volume":"139","author":"AM Marcinow","year":"2013","unstructured":"Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal A. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT\/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study. JAMA Otolaryngol Head Neck Surg. 2013;139:895\u2013902.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"6290_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1245\/s10434-014-3892-2","volume":"22","author":"JL Baker","year":"2015","unstructured":"Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, et al. Comparison of [99mTc]tilmanocept and filtered [99mTc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015;22:40\u20135.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR18","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1245\/s10434-015-4382-x","volume":"22","author":"A Agrawal","year":"2015","unstructured":"Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, et al. [99mTc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol. 2015;22:3708\u201315.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"6290_CR19","doi-asserted-by":"publisher","first-page":"S559","DOI":"10.1245\/s10434-015-4802-y","volume":"22","author":"JT Unkart","year":"2015","unstructured":"Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, et al. Comparison of post-injection site pain between technetium sulfur colloid and technetium tilmanocept in breast cancer patients undergoing sentinel lymph node biopsy. Ann Surg Oncol. 2015;22(Suppl 3):S559-565.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2967\/jnmt.117.194415","volume":"45","author":"JT Unkart","year":"2017","unstructured":"Unkart JT, Wallace AM. Use of 99mTc-tilmanocept as a single agent for sentinel lymph node identification in breast cancer: a retrospective pilot study. J Nucl Med Technol. 2017;45:181\u20134.","journal-title":"J Nucl Med Technol"},{"key":"6290_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/jso.24735","volume":"116","author":"JT Unkart","year":"2017","unstructured":"Unkart JT, Hosseini A, Wallace AM. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: results from a randomized, blinded clinical trial. J Surg Oncol. 2017;116:819\u201323.","journal-title":"J Surg Oncol"},{"key":"6290_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/tbj.13002","volume":"24","author":"JT Unkart","year":"2018","unstructured":"Unkart JT, Proudfoot J, Wallace AM. Outcomes of \u201cone-day\u201d vs \u201ctwo-day\u201d injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer. Breast J. 2018;24:526\u201330.","journal-title":"Breast J"},{"key":"6290_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jss.2018.07.042","volume":"233","author":"C Silvestri","year":"2019","unstructured":"Silvestri C, Christopher A, Intenzo C, Kairys JC, Kim S, Willis A, et al. Consecutive case series of melanoma sentinel node biopsy for Lymphoseek compared to sulfur colloids. J Surg Res. 2019;233:149\u201353.","journal-title":"J Surg Res"},{"key":"6290_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2967\/jnmt.118.225342","volume":"47","author":"BL Murphy","year":"2019","unstructured":"Murphy BL, Woodwick AR, Murphy KM, Chandler KJ, Johnson GB, Hunt CH, et al. 99mTc-Tilmanocept versus 99mTc-sulfur colloid in lymphoscintigraphy: sentinel lymph node identification and patient-reported pain. J Nucl Med Technol. 2019;47:300\u20134.","journal-title":"J Nucl Med Technol"},{"key":"6290_CR25","doi-asserted-by":"crossref","unstructured":"den Toom IJ, Mahieu R, van Rooij R, van Es RJJ, Hobbelink MGG, Krijger GC, et al. Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid. Eur J Nucl Med Mol Imaging. 2020;","DOI":"10.1007\/s00259-020-04984-8"},{"key":"6290_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2967\/jnumed.120.252064","volume":"62","author":"S Vidal-Sicart","year":"2021","unstructured":"Vidal-Sicart S, Rioja ME, Prieto A, Go\u00f1i E, G\u00f3mez I, Albala MD, et al. Sentinel lymph node biopsy in breast cancer with 99mTc-tilmanocept: a multicenter study on real-life use of a novel tracer. J Nucl Med. 2021;62:620\u20137.","journal-title":"J Nucl Med"},{"key":"6290_CR27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/diagnostics11071231","volume":"11","author":"C Doll","year":"2021","unstructured":"Doll C, Steffen C, Amthauer H, Thieme N, Elgeti T, Huang K, et al. Sentinel lymph node biopsy in early stages of oral squamous cell carcinoma using the receptor-targeted radiotracer 99mTc-tilmanocept. Diagnostics (Basel). 2021;11:1231.","journal-title":"Diagnostics (Basel)"},{"key":"6290_CR28","first-page":"275","volume":"40","author":"DD Rietbergen","year":"2021","unstructured":"Rietbergen DD, Pereira Arias-Bouda LM, van der Hage J, Vald\u00e9s Olmos RA. Does 99mTc-tilmanocept, as next generation radiotracer, meet with the requirements for improved sentinel node imaging? Rev Esp Med Nucl Imagen Mol. 2021;40:275\u201380.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"6290_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/coa.13798","volume":"46","author":"R Mahieu","year":"2021","unstructured":"Mahieu R, den Toom IJ, van Rooij R, van Es RJJ, Hobbelink MGG, Krijger GC, et al. Diagnostic accuracy of [99mTc]Tc-tilmanocept compared to [99mTc]Tc-nanocolloid for sentinel lymph node identification in early-stage oral cancer. Clin Otolaryngol. 2021;46:1383\u20138.","journal-title":"Clin Otolaryngol"},{"key":"6290_CR30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jso.26752","volume":"125","author":"A Eckhoff","year":"2022","unstructured":"Eckhoff A, Farrow NE, Silvestri C, Stroobant E, Intenzo C, Leddy M, et al. How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent. J Surg Oncol. 2022;125:712\u20138.","journal-title":"J Surg Oncol"},{"key":"6290_CR31","doi-asserted-by":"crossref","unstructured":"Mwagiru D, Shivashankar P, Wong E, Farlow D, Cambden B, Abdul-Razak M. Tilmanocept as a novel tracer for lymphatic mapping and sentinel lymph node biopsy in melanoma and oral cancer. ANZ J Surg. 2022;","DOI":"10.1111\/ans.17868"},{"key":"6290_CR32","first-page":"9421489","volume":"2022","author":"A Ferez-Pinzon","year":"2022","unstructured":"Ferez-Pinzon A, Corey SL, Rochani H, Rehl EA, Burak WE Jr. A prospective double-blinded randomized controlled trial comparing the intraoperative injection of technetium Tc 99m tilmanocept with technetium Tc 99m sulfur colloid in breast cancer lymphatic mapping. Breast J Hindawi. 2022;2022:9421489.","journal-title":"Breast J Hindawi"},{"key":"6290_CR33","first-page":"19","volume":"36","author":"Lymphoseek now FDA-approved for all solid tumors","year":"2014","unstructured":"Lymphoseek now FDA-approved for all solid tumors. Oncology Times. 2014;36:19.","journal-title":"Oncology Times"},{"key":"6290_CR34","unstructured":"EMA. Lymphoseek [Internet]. European Medicines Agency. 2018 [cited 2023 Jan 20]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lymphoseek."},{"key":"6290_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/jso.21439","volume":"101","author":"L Vermeeren","year":"2010","unstructured":"Vermeeren L, van der Ploeg IMC, Olmos RAV, Meinhardt W, Klop WMC, Kroon BBR, et al. SPECT\/CT for preoperative sentinel node localization. J Surg Oncol. 2010;101:184\u201390.","journal-title":"J Surg Oncol"},{"key":"6290_CR36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1245\/s10434-011-2031-6","volume":"19","author":"HJ Veenstra","year":"2012","unstructured":"Veenstra HJ, Vermeeren L, Olmos RAV, Nieweg OE. The additional value of lymphatic mapping with routine SPECT\/CT in unselected patients with clinically localized melanoma. Ann Surg Oncol. 2012;19:1018\u201323.","journal-title":"Ann Surg Oncol"},{"key":"6290_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1470-2045(09)70194-9","volume":"10","author":"A Stojadinovic","year":"2009","unstructured":"Stojadinovic A, Peoples GE, Jurgens JS, Howard RS, Schuyler B, Kwon KH, et al. Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. Lancet Oncol. 2009;10:849\u201354.","journal-title":"Lancet Oncol"},{"key":"6290_CR38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s00259-012-2129-5","volume":"39","author":"NS van den Berg","year":"2012","unstructured":"van den Berg NS, Brouwer OR, Klop WMC, Karakullukcu B, Zuur CL, Tan IB, et al. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-99mTc-nanocolloid. Eur J Nucl Med Mol Imaging. 2012;39:1128\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR39","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00259-015-3109-3","volume":"42","author":"NS van den Berg","year":"2015","unstructured":"van den Berg NS, Simon H, Kleinjan GH, Engelen T, Bunschoten A, Welling MM, et al. First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging. 2015;42:1639\u201347.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00259-018-4028-x","volume":"45","author":"GH KleinJan","year":"2018","unstructured":"KleinJan GH, Van Werkhoven E, van Den Berg NS, Karakullukcu MB, Zijlmans HJ, Van Der Hage JA, et al. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2018;45:1915\u201325.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6290_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10585-012-9497-x","volume":"29","author":"CA Tokin","year":"2012","unstructured":"Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, et al. The efficacy of tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012;29:681\u20136.","journal-title":"Clin Exp Metastasis"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06290-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:03:10Z","timestamp":1695956590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06290-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6290"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06290-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}